| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials
|
Hall, David B.
|
|
2005
|
26 |
3 |
p. 349-364
16 p.
|
artikel
|
| 2 |
An analysis of U.S. practices of paying research participants
|
Grady, Christine
|
|
2005
|
26 |
3 |
p. 365-375
11 p.
|
artikel
|
| 3 |
A sensitivity analysis of a randomized controlled trial of zinc in treatment of falciparum malaria in children
|
Fox, Matthew P.
|
|
2005
|
26 |
3 |
p. 281-289
9 p.
|
artikel
|
| 4 |
Can keeping clinical trial participants blind to their study treatment adversely affect subsequent care?
|
Blader, Joseph C.
|
|
2005
|
26 |
3 |
p. 290-299
10 p.
|
artikel
|
| 5 |
Design and analysis of trials with rare outcomes: Examples from trials in herpes transmission and influenza prophylaxis
|
Keene, Oliver
|
|
2005
|
26 |
3 |
p. 311-322
12 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2005
|
26 |
3 |
p. iii-
1 p.
|
artikel
|
| 7 |
Effect of acyclovir on herpetic ocular recurrence using a structural nested model
|
Cole, Stephen R.
|
|
2005
|
26 |
3 |
p. 300-310
11 p.
|
artikel
|
| 8 |
Estimating live birth rates after ovulation induction in polycystic ovary syndrome: Sample size calculations for the pregnancy in polycystic ovary syndrome trial
|
Myers, Evan R.
|
|
2005
|
26 |
3 |
p. 271-280
10 p.
|
artikel
|
| 9 |
How to control measurement variation in estimating the mean intraocular pressure reducing effect at a specific point in time
|
Hedman, Katarina
|
|
2005
|
26 |
3 |
p. 402-415
14 p.
|
artikel
|
| 10 |
Information for Authors
|
|
|
2005
|
26 |
3 |
p. I-II
nvt p.
|
artikel
|
| 11 |
Letter from the Editors
|
|
|
2005
|
26 |
3 |
p. 269-270
2 p.
|
artikel
|
| 12 |
[No title]
|
Anderson, James R.
|
|
2005
|
26 |
3 |
p. 416-417
2 p.
|
artikel
|
| 13 |
Practical applications of usability theory to electronic data collection for clinical trials
|
Schmier, Jordana K.
|
|
2005
|
26 |
3 |
p. 376-385
10 p.
|
artikel
|
| 14 |
Psychotherapy in controlled psychopharmacology trials. Does it matter if we ignore it?
|
Koek, Ralph J.
|
|
2005
|
26 |
3 |
p. 338-348
11 p.
|
artikel
|
| 15 |
Response to “The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes”
|
Antuono, Piero
|
|
2005
|
26 |
3 |
p. 417-418
2 p.
|
artikel
|
| 16 |
Sample sizes for clinical trials with time-to-event endpoints and competing risks
|
Schulgen, Gabi
|
|
2005
|
26 |
3 |
p. 386-396
11 p.
|
artikel
|
| 17 |
The effect of scientific misconduct on the results of clinical trials: A Delphi survey
|
Al-Marzouki, Sanaa
|
|
2005
|
26 |
3 |
p. 331-337
7 p.
|
artikel
|
| 18 |
Trying to improve the compliance to colorectal cancer screening: A complex study design for a complex planning question
|
Giorgi Rossi, Paolo
|
|
2005
|
26 |
3 |
p. 323-330
8 p.
|
artikel
|
| 19 |
Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study
|
Avins, Andrew L.
|
|
2005
|
26 |
3 |
p. 397-401
5 p.
|
artikel
|
Tijdschrift beschrijving